Clin2
NCT05099315Possibly a fitRecruiting

Gut microbiome study in adults with severe eczema

Atopic Dermatitis

Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.

This trial studies the gut microbiome in people with moderate to severe atopic dermatitis (eczema) who are starting or already receiving systemic (whole-body) treatment. It may help researchers understand what changes in gut bacteria are linked to eczema and to treatment response.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have moderate to severe atopic dermatitis (eczema).
  • You need systemic treatment for your eczema (whole-body treatment).
  • You must be 18 years or older when systemic treatment begins.
  • You cannot be pregnant.
  • You cannot be breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00605878Recruiting
Skin microbiome study in healthy people and eczema patients

This study looks at the types of germs on the skin (skin microbiome) in healthy people and people with skin conditions, including atopic dermatitis (eczema). Researchers collect skin samples to understand how skin germs differ and how that may relate to skin health.

Bethesda, Maryland
NCT06487000Not yet recruiting· Phase 2
Oral medication study for moderate to severe eczema

This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.

NCT06947993Recruiting· Phase 2
Study of a new treatment for moderate to severe eczema

This study tests an experimental treatment for people with moderate to severe eczema that has lasted at least a year. It aims to see if the new medicine can help control symptoms better than current options.

Birmingham, Alabama
NCT04170244Recruiting
Skin microbiome study in atopic dermatitis and psoriasis

This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.

Rochester, New York
NCT06547372Recruiting
Dietary changes for eczema relief

This study tests whether a specific diet can help manage mild to moderate eczema. It involves eating whole foods provided by the researchers for a set period and tracking your skin health.

Singapore, Singapore
NCT05819463Recruiting
Study care for moderate to severe atopic dermatitis

This trial looks at treatment and medical care for teens and adults with moderate to severe atopic dermatitis (eczema). It may help by testing ways to manage symptoms better based on severity and current treatment needs.

Basel

Hear when a new Atopic Dermatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.